Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia
Blood · 31.03.2023
DOI: 10.1182/blood.2023019765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, online erschienen am 31.03.2023. Verfasst von Zhenhua Li und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Hauptthemen laut MEDLINE: Down Syndrome, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 24-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, NEI NIH HHS.
Abstract (Originalsprache)
Trisomy 21, the genetic cause of Down syndrome (DS), is the most common congenital chromosomal anomaly. It is associated with a 20-fold increased risk of acute lymphoblastic leukemia (ALL) during childhood and results in distinctive leukemia biology. To comprehensively define the genomic landscape of DS-ALL, we performed whole genome sequencing and whole-transcriptome sequencing (RNA-Seq) on 295 cases. Our integrated genomic analyses identified 15 molecular subtypes of DS-ALL, with marked enrichment of CRLF2-r, IGH::IGF2BP1, and C/EBP altered (C/EBPalt) subtypes compared to 2257 non-DS-ALL cases. We observed abnormal activation of the CEBPD, CEBPA, and CEBPE genes in 10.5% of DS-ALL cases, via a variety of genomic mechanisms, including chromosomal rearrangements and noncoding mutations leading to enhancer hijacking. 42.3% of C/EBP-activated DS-ALL also have concomitant FLT3 point mutation or indel, relative to 4.1% in other subtypes (P=7.2×10-6). CEBPD overexpression enhanced the differentiation of mouse hematopoietic progenitor cells into pro-B cells in vitro, particularly in a DS genetic background. Notably, RAG-mediated somatic genomic abnormalities were common in DS-ALL, accounting for a median of 27.5% of structural alterations, compared to 7.7% in non-DS-ALL (P=2.1×10-12). Unsupervised hierarchical clustering analyses of CRLF2-rearranged DS-ALL identified substantial heterogeneity within this group, with the BCR::ABL1-like subset linked to an inferior event-free survival (hazard ratio=5.27, P=9.3×10-8), even after adjusting for known clinical risk factors (hazard ratio=4.32; P=0.0020). These results provide important insights into the biology of DS-ALL and point to opportunities for targeted therapy and treatment individualization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN.
- Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN.
- Department of Pediatrics, Baylor College of Medicine, Houston, TX.
- Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN.
- Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN.
- Department of Pathobiology and Laboratory Medicine, University of Toronto, Toronto, ON, Canada.
ORCID-Profile: Jacob J Junco, Meenakshi Devidas, Yizhen Li, Wenjian Yang, Brent L Wood, Lauren Sanclemente, Charles G Mullighan, Jiyang Yu, Philip J Lupo, Karen R Rabin
Förderung
- NCI NIH HHS
- NIH HHS
- NEI NIH HHS
- NCRR NIH HHS
- NIGMS NIH HHS
- NICHD NIH HHS
- NIEHS NIH HHS
Zitieren
APA
Li, Z., Chang, T. C., Junco, J. J., Devidas, M., Li, Y., Yang, W., Huang, X., Hedges, D. J., Cheng, Z., Shago, M., Carroll, A. J., Heerema, N. A., Gastier-Foster, J., Wood, B. L., Borowitz, M. J., Sanclemente, L., Raetz, E. A., Hunger, S. P., Feingold, E., …, & Yang, J. J. (2023). Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia. Blood. https://doi.org/10.1182/blood.2023019765
Vancouver
Li Z, Chang TC, Junco JJ, Devidas M, Li Y, Yang W, et al. Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia. Blood. 2023. doi:10.1182/blood.2023019765
BibTeX
@article{Li2023,
author = {Li, Zhenhua and Chang, Ti-Cheng and Junco, Jacob J and Devidas, Meenakshi and Li, Yizhen and Yang, Wenjian and Huang, Xin and Hedges, Dale J and Cheng, Zhongshan and Shago, Mary and Carroll, Andrew J and Heerema, Nyla A and Gastier-Foster, Julie and Wood, Brent L and Borowitz, Michael J and Sanclemente, Lauren and Raetz, Elizabeth A and Hunger, Stephen P and Feingold, Eleanor and Rosser, Tracie C and Sherman, Stephanie L and Loh, Mignon L and Mullighan, Charles G and Yu, Jiyang and Wu, Gang and Lupo, Philip J and Rabin, Karen R and Yang, Jun J},
title = {Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia},
journal = {Blood},
year = {2023},
doi = {10.1182/blood.2023019765}
}
EUVIMED